Antimicrobial Agents and Chemotherapy, November 2006, p. 3724-3733, Vol. 50, No. 11
0066-4804/06/$08.00+0 doi:10.1128/AAC.00644-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Inhibition of Multiple Subtypes of Influenza A Virus in Cell Cultures with Morpholino Oligomers
Qing Ge,1,
Manoj Pastey,2,
Darwyn Kobasa,3,
Piliapan Puthavathana,4
Christopher Lupfer,2
Richard K. Bestwick,5
Patrick L. Iversen,5
Jianzhu Chen,1 and
David A. Stein5*
Center for Cancer Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139,1
Department of Biomedical Sciences, College of Veterinary Medicine, Oregon State University, Corvallis, Oregon 97331,2
Public Health Agency of Canada, Winnipeg, Manitoba, Canada,3
Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand,4
AVI BioPharma Inc., Corvallis, Oregon 973335
Received 25 May 2006/
Returned for modification 7 July 2006/
Accepted 19 August 2006
Peptide-conjugated phosphorodiamidate morpholino oligomers (P-PMO) are single-stranded nucleic acid-like antisense agents that can reduce gene expression by sterically blocking complementary RNA sequence. P-PMO are water soluble and nuclease resistant, and they readily achieve uptake into cells in culture under standard conditions. Eight P-PMO, each 20 to 22 bases in length, were evaluated for their ability to inhibit influenza A virus (FLUAV) A/PR/8/34 (H1N1) replication in cell culture. The P-PMO were designed to base pair with FLUAV RNA sequences that are highly conserved across viral subtypes and considered critical to the FLUAV biological-cycle, such as gene segment termini and mRNA translation start site regions. Several P-PMO were highly efficacious, each reducing viral titer in a dose-responsive and sequence-specific manner in A/PR/8/34-infected cells. Two P-PMO, one designed to target the AUG translation start site region of PB1 mRNA and the other the 3'-terminal region of nucleoprotein viral genome RNA, also proved to be potent against several other FLUAV strains, including A/WSN/33 (H1N1), A/Memphis/8/88 (H3N2), A/Eq/Miami/63 (H3N8), A/Eq/Prague/56 (H7N7), and the highly pathogenic A/Thailand/1(KAN-1)/04 (H5N1). The P-PMO exhibited minimal cytotoxicity in cell viability assays. High efficacy by two of the P-PMO against multiple FLUAV subtypes suggests that these oligomers represent a broad-spectrum therapeutic approach against a high percentage of known FLUAV strains.
* Corresponding author. Mailing address: AVI BioPharma Inc., 4575 SW Research Way, Corvallis, OR 97333. Phone: (541) 753-3635. Fax: (541) 754-3545. E-mail: steind{at}avibio.com.
Published ahead of print on 11 September 2006.
These authors contributed equally to this work.
Antimicrobial Agents and Chemotherapy, November 2006, p. 3724-3733, Vol. 50, No. 11
0066-4804/06/$08.00+0 doi:10.1128/AAC.00644-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Stone, J. K., Rijnbrand, R., Stein, D. A., Ma, Y., Yang, Y., Iversen, P. L., Andino, R.
(2008). A Morpholino Oligomer Targeting Highly Conserved Internal Ribosome Entry Site Sequence Is Able To Inhibit Multiple Species of Picornavirus. Antimicrob. Agents Chemother.
52: 1970-1981
[Abstract]
[Full Text]
-
Gabriel, G., Nordmann, A., Stein, D. A., Iversen, P. L., Klenk, H.-D.
(2008). Morpholino oligomers targeting the PB1 and NP genes enhance the survival of mice infected with highly pathogenic influenza A H7N7 virus. J. Gen. Virol.
89: 939-948
[Abstract]
[Full Text]
-
Zhang, Y.-J., Bonaparte, R. S., Patel, D., Stein, D. A., Iversen, P. L.
(2008). Blockade of viral interleukin-6 expression of Kaposi's sarcoma-associated herpesvirus. Molecular Cancer Therapeutics
7: 712-720
[Abstract]
[Full Text]
-
Vagnozzi, A., Stein, D. A., Iversen, P. L., Rieder, E.
(2007). Inhibition of Foot-and-Mouth Disease Virus Infections in Cell Cultures with Antisense Morpholino Oligomers. J. Virol.
81: 11669-11680
[Abstract]
[Full Text]
-
Wu, R. P., Youngblood, D. S., Hassinger, J. N., Lovejoy, C. E., Nelson, M. H., Iversen, P. L., Moulton, H. M.
(2007). Cell-penetrating peptides as transporters for morpholino oligomers: effects of amino acid composition on intracellular delivery and cytotoxicity. Nucleic Acids Res
0: gkm478v1-10
[Abstract]
[Full Text]
-
Deas, T. S., Bennett, C. J., Jones, S. A., Tilgner, M., Ren, P., Behr, M. J., Stein, D. A., Iversen, P. L., Kramer, L. D., Bernard, K. A., Shi, P.-Y.
(2007). In Vitro Resistance Selection and In Vivo Efficacy of Morpholino Oligomers against West Nile Virus. Antimicrob. Agents Chemother.
51: 2470-2482
[Abstract]
[Full Text]
-
Burrer, R., Neuman, B. W., Ting, J. P. C., Stein, D. A., Moulton, H. M., Iversen, P. L., Kuhn, P., Buchmeier, M. J.
(2007). Antiviral Effects of Antisense Morpholino Oligomers in Murine Coronavirus Infection Models. J. Virol.
81: 5637-5648
[Abstract]
[Full Text]
Copyright © 2006 by the American Society for Microbiology. All rights reserved.